MX2009008875A - Producto que contiene probiotico inactivado para niños o infantes. - Google Patents

Producto que contiene probiotico inactivado para niños o infantes.

Info

Publication number
MX2009008875A
MX2009008875A MX2009008875A MX2009008875A MX2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A
Authority
MX
Mexico
Prior art keywords
children
inactivated probiotic
probiotic
infants
product containing
Prior art date
Application number
MX2009008875A
Other languages
English (en)
Inventor
Robert J Mcmahon
Josef Neu
Udo Herz
William Michael Russell
Original Assignee
Mead Johnson Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39469924&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009008875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mead Johnson Nutrition Co filed Critical Mead Johnson Nutrition Co
Publication of MX2009008875A publication Critical patent/MX2009008875A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe un producto para niños o infantes que comprende por lo menos un probiótico inactivado, en donde el producto se formula para suministrar entre aproximadamente 1x104 a aproximadamente 1x1010 equivalentes celulares de probiótico inactivado por kg de peso corporal por día a un niño o infante, y en donde, además de las características reproductivas, por lo menos un probiótico inactivado conserva las características reactivas biológicas celulares y moleculares del probiótico viable.
MX2009008875A 2007-02-28 2008-02-22 Producto que contiene probiotico inactivado para niños o infantes. MX2009008875A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90412207P 2007-02-28 2007-02-28
PCT/US2008/054717 WO2008106373A1 (en) 2007-02-28 2008-02-22 Product containing inactivated probiotic for children or infants

Publications (1)

Publication Number Publication Date
MX2009008875A true MX2009008875A (es) 2009-08-28

Family

ID=39469924

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009008875A MX2009008875A (es) 2007-02-28 2008-02-22 Producto que contiene probiotico inactivado para niños o infantes.
MX2009009119A MX2009009119A (es) 2007-02-28 2008-02-22 Metodo para tratar o prevenir la inflamacion sistemica.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009009119A MX2009009119A (es) 2007-02-28 2008-02-22 Metodo para tratar o prevenir la inflamacion sistemica.

Country Status (14)

Country Link
US (2) US9408818B2 (es)
EP (2) EP2124977B9 (es)
CN (3) CN101678053B (es)
AT (1) ATE544457T1 (es)
BR (2) BRPI0808052A2 (es)
CA (2) CA2676956C (es)
ES (2) ES2388198T5 (es)
HK (2) HK1136969A1 (es)
MX (2) MX2009008875A (es)
MY (2) MY145769A (es)
PL (2) PL2114423T3 (es)
RU (2) RU2468808C2 (es)
TW (2) TWI418355B (es)
WO (2) WO2008106372A1 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
US9034314B2 (en) * 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
ES2639364T3 (es) * 2009-04-29 2017-10-26 Ganeden Biotech, Inc. Formulación de membrana celular bacteriana
CN102802648A (zh) * 2009-05-11 2012-11-28 雀巢产品技术援助有限公司 约氏乳杆菌La1 NCC533(CNCM I-1225)和免疫病症
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
DK2525811T4 (en) 2010-01-19 2019-04-08 Abbott Lab COMPOSITION, INCLUDING LACTOBACILLUS RHAMNOSUS HN001 AND PREBIOTICS FOR USE IN TREATMENT OF ALLERGIC LUNG DISEASE
US9301982B2 (en) 2010-04-14 2016-04-05 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
WO2012062900A2 (en) * 2010-11-11 2012-05-18 Nestec S.A. Frozen confections containing probiotic micro-organisms
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2452576A1 (en) * 2010-11-11 2012-05-16 Nestec S.A. Extruded non-replicating probiotic micro-organisms and their health benefits
EP2455094A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
US9545415B2 (en) * 2012-01-06 2017-01-17 Skyview Enterprise Ltd. Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CA3176938A1 (en) * 2013-08-09 2015-02-12 Ab-Biotics, S.A. Probiotic for infantile excessive crying
EP3091861A1 (en) * 2013-11-25 2016-11-16 Nestec S.A. Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations
AU2014356449B2 (en) * 2013-11-29 2018-07-26 Société des Produits Nestlé S.A. Age-tailored nutritional compositions with a varying protein content
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
KR20220151045A (ko) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 면역 조정
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MD3240554T2 (ro) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3206700T3 (pl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Kompozycje zawierające szczepy bakteryjne
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
ME03003B (me) 2015-11-20 2018-10-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
RS58869B1 (sr) 2016-03-04 2019-08-30 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
ES2657665B1 (es) * 2016-09-05 2018-12-17 Pedro Jose DE LA FUENTE BLASCO Productos para la salud con probióticos inactivados y uso de dichos productos
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN107115362A (zh) * 2017-04-28 2017-09-01 青岛东海药业有限公司 凝结芽孢杆菌在制备预防或治疗支气管哮喘制剂中的应用
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
KR20200015575A (ko) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 세균 균주를 포함하는 조성물
JP6884889B2 (ja) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
CN108041607A (zh) * 2017-12-26 2018-05-18 广州普正生物科技有限公司 一种护齿益生菌咀嚼软胶囊
RU2770463C1 (ru) * 2020-10-14 2022-04-18 федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный технический университет им. И.И. Ползунова" (АлтГТУ) Способ производства мягкого сыра
TWI802009B (zh) * 2021-09-16 2023-05-11 創百股份有限公司 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
US6180100B1 (en) 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
DE69819477D1 (de) 1998-06-17 2003-12-11 Nestle Sa Mobile genetische Elemente als Werkzeuge zur genetischen Modifikation von L. delbrueckii oder L. helveticus
US6399055B1 (en) 1998-10-27 2002-06-04 Compagnie Gervais Danone Method and composition for treatment of infant diarrhea
KR20010101171A (ko) 1998-12-11 2001-11-14 추후기재 비뇨생식기 감염의 치료 및 예방을 위한 락토바실러스의경구 투여
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6613549B2 (en) * 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
BR0116349A (pt) 2000-12-18 2003-12-23 Probiohealth Llc Compostos probióticos derivados da cepa ke01 de lactobacillus casei
KR100419132B1 (ko) 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EA006397B1 (ru) 2001-02-06 2005-12-29 Сосьете Де Продюи Нестле С.А. Связывающие эндотоксин штаммы лактобактерий и бифидобактерий, обладающие гидрофобными свойствами, и способы их применения
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US20030092163A1 (en) 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
PE20030283A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US20050100531A1 (en) 2002-06-13 2005-05-12 John Bienenstock Probiotic therapies
JP4176715B2 (ja) 2002-06-28 2008-11-05 プレバ、バイオテック、ソシエダッド、アノニマ プロバイオティクス菌株、その選択方法、その組成物、およびその使用
WO2004069156A2 (en) 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
WO2004087178A1 (en) 2003-03-31 2004-10-14 Alimentary Health Limited A formulation comprising a bacterial strain
ES2355382T3 (es) * 2003-06-23 2011-03-25 Nestec S.A. Fórmula para lactantes o de continuación.
US7125963B2 (en) 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
US20080255252A1 (en) * 2004-03-15 2008-10-16 Tissugen Pty. Ltd. Infectious Aetiology of Prostatic Disease and Methods to Identify Causative Agents
EP2308566B1 (en) 2005-04-08 2017-07-05 The Procter and Gamble Company Use of orally administered probiotic bifidobacteria for human beauty benefits
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060233752A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
WO2006124630A2 (en) * 2005-05-13 2006-11-23 New England Medical Center Hospitals, Inc. Compositions and methods for enhancing the efficacy of vaccines
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation

Also Published As

Publication number Publication date
PL2124977T3 (pl) 2012-07-31
RU2009135873A (ru) 2011-04-10
TW200906426A (en) 2009-02-16
RU2468808C2 (ru) 2012-12-10
EP2114423B2 (en) 2020-01-01
EP2124977B9 (en) 2012-05-02
BRPI0808052A2 (pt) 2014-06-24
RU2009135871A (ru) 2011-04-10
RU2468807C2 (ru) 2012-12-10
EP2124977B1 (en) 2012-02-08
MY145769A (en) 2012-04-13
CA2679374A1 (en) 2008-09-04
CA2676956A1 (en) 2008-09-04
EP2114423A1 (en) 2009-11-11
MY151892A (en) 2014-07-14
TWI418355B (zh) 2013-12-11
ATE544457T1 (de) 2012-02-15
US9408818B2 (en) 2016-08-09
HK1136969A1 (en) 2010-07-16
CN101636172A (zh) 2010-01-27
TW200900075A (en) 2009-01-01
ES2388198T5 (es) 2020-07-14
MX2009009119A (es) 2009-09-04
EP2124977A1 (en) 2009-12-02
BRPI0808145A2 (pt) 2021-03-23
US20080206212A1 (en) 2008-08-28
CN105796607A (zh) 2016-07-27
TWI494114B (zh) 2015-08-01
US20080206213A1 (en) 2008-08-28
ES2381232T3 (es) 2012-05-24
WO2008106372A1 (en) 2008-09-04
CN101678053B (zh) 2015-12-16
ES2388198T3 (es) 2012-10-10
WO2008106373A1 (en) 2008-09-04
CA2679374C (en) 2016-05-31
US9408819B2 (en) 2016-08-09
EP2114423B1 (en) 2012-06-06
HK1141729A1 (zh) 2010-11-19
PL2114423T3 (pl) 2012-10-31
CA2676956C (en) 2017-06-13
CN101678053A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
MY151892A (en) Product containing inactivated probiotic for infants
NZ612472A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
WO2007000762A3 (en) Baby and toddler carrier
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
MX2011012063A (es) Formula alimenticia para bebes y niños pequeños que comprenden probioticos para bebes y niños pequeños.
MX2009011931A (es) Articulos para incontinencia del adulto, desechables y especificos de genero.
PT1638414E (pt) Fórmula para lactentes ou fórmula de transição
NZ612386A (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
NZ613180A (en) Methods of using human milk oligosaccharides for improving airway respiratory health
WO2009099971A3 (en) Modular feeding bottle
MY156779A (en) Absorbent article
MX2007003903A (es) Un articulo absorbente que tiene cierres que se pueden volver a sujetar.
PL1871400T3 (pl) Kwas uronowy i probiotyki
MY145410A (en) Method for preventing or treating respiratory infections and acute otitis media in infants
MY151518A (en) Carrying device
NZ613335A (en) Agent for inducing interferon production containing lactic acid bacteria
TW200600543A (en) Process for the production of porous moulded articles containing alginate
MX347403B (es) Composiciones anti-regurgitacion y/o anti-reflujo gastroesofagico, preparacion y usos.
WO2004068968A8 (en) Baby feeding formula and system
CN201755321U (zh) 一种防摔婴儿用奶瓶
GB2426713A8 (en) Feeding bottle or pacifier with odour
CN202698550U (zh) 前背式婴儿背带
WO2010010553A3 (en) Insulating and singing doll cover for baby feeding bottles
WO2006116117A3 (en) A harness
曹丹 et al. From Lullaby to Requiem

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights